Clarissa Anna Pisano

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: ISCIENCE. 2026;29(3):114882
Identification of DARPP-32 as a novel sleep regulator in physiological conditions and experimental Parkinsonism
Pisano CA; Santino ML; Russotto A; Fisone G
Article: PROGRESS IN NEUROBIOLOGY. 2023;231:102536
A mouse model of sleep disorders in Parkinson's disease showing distinct effects of dopamine D2-like receptor activation
Medeiros DDC; Plewnia C; Mendes RV; Pisano CA; Boi L; Moraes MFD; Aguiar CL; Fisone G
Article: BRITISH JOURNAL OF PHARMACOLOGY. 2023;180(7):927-942
Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l-Dopa-induced dyskinesia
Pisano CA; Mercatelli D; Mazzocchi M; Brugnoli A; Morella I; Fasano S; Zaveri NT; Brambilla R; O'Keeffe GW; Neubig RR; Morari M
Article: NEUROBIOLOGY OF DISEASE. 2020;144:105044
Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats
Brugnoli A; Pisano CA; Morari M
Article: BRITISH JOURNAL OF PHARMACOLOGY. 2020;177(17):3957-3974
6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in thesubstantia nigra pars reticulata
Vegas-Suarez S; Pisano CA; Requejo C; Bengoetxea H; Lafuente JV; Morari M; Miguelez C; Ugedo L
Article: NEUROPHARMACOLOGY. 2020;167:108006
Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease
Pisano CA; Brugnoli A; Novello S; Caccia C; Keywood C; Melloni E; Vailati S; Padoani G; Morari M
Article: JOURNAL OF MEDICINAL CHEMISTRY. 2020;63(5):2688-2704
Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease Models.
Kamakolanu UG; Meyer ME; Yasuda D; Polgar WE; Marti M; Mercatelli D; Pisanò CA; Brugnoli A; Morari M; Zaveri NT
Article: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2019;7(3):e00484
Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes
Mercatelli D; Bolognesi P; Frassineti M; Pisano CA; Longo F; Shimshek DR; Morari M
Article: HANDBOOK OF EXPERIMENTAL PHARMACOLOGY. 2019;254:213-232
NOP Receptor Ligands and Parkinson's Disease.
Mercatelli D; Pisanò CA; Novello S; Morari M
Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2018;367(3):442-451
Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia
Gardoni F; Morari M; Kulisevsky J; Brugnoli A; Novello S; Pisano CA; Caccia C; Mellone M; Melloni E; Padoani G; Sosti V; Vailati S; Keywood C
Article: BRITISH JOURNAL OF PHARMACOLOGY. 2018;175(5):782-796
Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists
Arcuri L; Novello S; Frassineti M; Mercatelli D; Pisano CA; Morella I; Fasano S; Journigan BV; Meyer ME; Polgar WE; Brambilla R; Zaveri NT; Morari M
Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2018;364(2):198-206
Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia
Morari M; Brugnoli A; Pisano CA; Novello S; Caccia C; Melloni E; Padoani G; Vailati S; Sardina M

Alla övriga publikationer

Preprint: BIORXIV. 2026
DARPP-32 in motor cortex regulates structural and synaptic plasticity in corticothalamic neurons and enables motor learning
Anna PC; Alina A; Valeria S; Ayu T; Gilberto F; Emanuela S; Anders B

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI